Repurposing SGLT-2 Inhibitors to Target Aging: Available Evidence and Molecular Mechanisms.
將此醫學文章的標題翻譯為繁體中文:「將SGLT-2抑制劑重新用於針對老化:現有證據與分子機制。」
Int J Mol Sci 2023-04-03
Canagliflozin shares common mTOR and MAPK signaling mechanisms with other lifespan extension treatments.
Canagliflozin與其他延長壽命治療方法共享常見的mTOR和MAPK信號傳遞機制。
Life Sci 2023-07-24
SGLT2 Inhibitors in Aging-Related Cardiovascular Disease: A Review of Potential Mechanisms.
SGLT2抑制劑在與老化相關的心血管疾病中的應用:潛在機制的綜述。
Am J Cardiovasc Drugs 2023-11-06
Immunomodulatory Effects of SGLT2 Inhibitors-Targeting Inflammation and Oxidative Stress in Aging.
SGLT2抑制劑的免疫調節作用-針對老化中的炎症和氧化壓力。
Int J Environ Res Public Health 2023-09-13